Subsequently, anti-MDA5+ DM patients, along with SLE patients presenting with anti-MDA5 or anti-RNP alone as controls, were subjected to a series of in vitro experiments in order to explore the possible antibody-mediated innate immune response. Here, RNPC3 is linked to dermatomyositis.